Neuroprotective peptide inhibitors of AP-1 signaling and...

Details Neuroprotective peptide inhibitors of AP-1 signaling and... Neuroprotective peptide inhibitors of AP-1 signaling and...

2007-01-31

2011-11-22

Ulm, John (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000

Reexamination Certificate

active

08063012

ABSTRACT:
The present invention provides AP-1 signaling inhibitory peptides of SEQ ID NOS:54-57, compositions of the peptides, and methods of treatment of neurological disorders by administration of the peptide(s) or compositions.

REFERENCES:
patent: 5843698 (1998-12-01), Sorensen
patent: 6074815 (2000-06-01), Sorensen
patent: 6150127 (2000-11-01), Sorensen
patent: 2007/0031832 (2007-02-01), Watt
patent: 2007/0060514 (2007-03-01), Bonny
patent: 1629637 (2005-06-01), None
patent: 1776958 (2007-04-01), None
patent: 1811033 (2007-07-01), None
patent: WO 01/32156 (2001-05-01), None
patent: WO 2004/074479 (2004-09-01), None
patent: WO 2006/017913 (2006-02-01), None
patent: WO 2007/031098 (2007-03-01), None
patent: WO 2008/034161 (2008-03-01), None
patent: WO 2008/034162 (2008-03-01), None
patent: WO 2008/154700 (2008-12-01), None
Bennett, B.L., “c-Jun N-Terminal Kinase-Dependent Mechanisms in Respiratory Disease,” Eur. Respir. Journal, 2006, pp. 651-661, vol. 28.
Florin, I. et al., “Identification of Novel AP-1 Target Genes in Fibroblasts Regulated During Cutaneous Wound Healing,” Oncogene, 2004, pp. 7005-7017, vol. 23, No. 42.
Nguyen, C. et al., “Chemogenomic Identification of Ref-1/AP-1 as a Therapeutic Target for Asthma,” Proc. Nat. Acad. Sci., Feb. 4, 2003, pp. 1169-1173, vol. 100, No. 3.
PCT International Search Report, PCT Application No. PCT/AU2007/000092, Apr. 2, 2007, 3 pages.
PCT International Preliminary Examination Report, PCT Application No. PCT/AU2007/000092, Mar. 24, 2009, 7 pages.
PCT International Search Report and Written Opinion, PCT Application No. PCT/AU2007/000121, Apr. 5, 2007, 8 pages.
PCT International Preliminary Examination Report, PCT Application No. PCT/AU2007/000121, Mar. 24, 2009, 4 pages.
PCT International Search Report and Written Opinion, PCT Application No. PCT/AU2008/000903, Oct. 15, 2008, 13 pages.
PCT International Preliminary Report on Patentability, PCT Application No. PCT/AU2008/000903, Dec. 22, 2009, 7 pages.
RefSeq Accession No. XP—975325.1, NCBI Sequence Viewer v2.0, 1 page, [Online] [Retrieved on May 3, 2007].
RefSeq Accession No. ZP—01044355.1, NCBI Sequence Viewer v2.0, 2 pages, [Online] [Retrieved on May 3, 2007].
RefSeq Accession No. YP—284595.1, NCBI Sequence Viewer v2.0, 2 pages, [Online] [Retrieved on May 3, 2007].
Yates, S. et al.“Transcription Factor Activation in Response to Cutaneous Injury: Role of AP-1 in Reepithelialization,” Wound Repair Regeneration, 2002, pp. 5-15, vol. 10, No. 1.

Affiliated with

Also associated with

Rating

Neuroprotective peptide inhibitors of AP-1 signaling and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neuroprotective peptide inhibitors of AP-1 signaling and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotective peptide inhibitors of AP-1 signaling and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4267975